This session provides an overview of the principles of safety reporting associated with marketed medicinal products including spontaneous reporting systems.

Have an account?

Drug Safety and Pharmacovigilance Across the Product Lifecycle

Session 12: Post-Marketing Safety Principles and Spontaneous Case Reporting

Session Chair(s)

Jill W. Buckley, PharmD

Be informed and stay engaged.